Table 1 Age, sex and site distribution status among the study population
From: 18F-FDG PET/CT in therapy response assessment: oligometastatic colorectal cancer
Total No & (%) | Synchronous No & (%) | Metachronous No & (%) | X2 | P | ||
|---|---|---|---|---|---|---|
79 (100%) | 35 (44.3%) | 44 (55.7%) | ||||
Age | Mean ± SD | 57.0 ± 13.3 | 57.0 ± 14.6 | 57.0 ± 12.3 | 0.03 | 0.98 |
Sex | Male | 57 (72.2%) | 27 (77.1%) | 30 (68.2%) | 0.77 | 0.37 |
Female | 22 (27.8%) | 8 (22.9%) | 14 (31.8%) | |||
Primary Site | Ascending | 32 (40.5%) | 12 (34.3%) | 20 (45.5%) | 2.33 | 0.51 |
Transverse | 4 (5.1%) | 2 (5.7%) | 2 (4.5%) | |||
Descending | 27 (34.2%) | 15 (42.9%) | 12 (27.3%) | |||
Recto-Sigmoid | 16 (20.3%) | 6 (17.1%) | 10 (22.7%) |